Refining the immune class of hepatocellular carcinoma
Roser Pinyol(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Elizabeth Harrod(Royal Surrey County Hospital), Daniela Sia(Icahn School of Medicine at Mount Sinai), J. Anderson, Chinbold Enkhbold(National Center for Communicable Diseases), Michael Donovan(Hunan University), Marc Puigvehí(Parc de Salut), Philipp K. Haber(Icahn School of Medicine at Mount Sinai), Andrew Uzilov(Sema4 (United States)), Jaclyn Neely(Bristol-Myers Squibb (United States)), Patricia Taik(Sema4 (United States)), Erdenebileg Taivanbaatar, Augusto Villanueva(NYU Langone Health), Vincenzo Mazzaferro(Fondazione IRCCS Istituto Nazionale dei Tumori), Miguel Torres‐Martín(Tisch Hospital), Wei Qiang Leow(SingHealth), Scott L. Friedman(Icahn School of Medicine at Mount Sinai), Swan N. Thung(Icahn School of Medicine at Mount Sinai), Chinburen Jigjidsuren, Huan Wang(Chengdu Military General Hospital), Miho Maeda, Carla Montironi(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Sasan Roayaie(White Plains Hospital), Myron Schwartz(Icahn School of Medicine at Mount Sinai)
Cited by 0
Related Papers
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
|Journal of Biological Chemistry|2000|2.1k